| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA656543 | F | Inhibition of tumor growth of CX-1 cell line at 600 mg/kg | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA656544 | F | In vitro inhibition of growth of human carcinoma CX-1 cell line (clonogenic assay). | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 3. | ALA656545 | F | Inhibitory concentration against growth of human colon carcinoma cells | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
| 4. | ALA1001016 | F | Cytotoxicity against human CX-1 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA1035172 | F | In vivo antitumor activity against human CX-1 cells at 600 mg/kg administered on day 1, 5, 9 and 13 relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA1035173 | F | In vivo antitumor activity against human CX-1 cells at 300 mg/kg administered on day 1, 5, 9 and 13 relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA1035174 | F | In vivo antitumor activity against human CX-1 cells at 150 mg/kg administered on day 1, 5,9 and 13 relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA1035175 | F | In vivo antitumor activity against human CX-1 cells at 75 mg/kg administered on day 1, 5,9 and 13 relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA1030875 | F | Growth inhibition of human CX-1 cells assessed as zone units at 50 ug/disk by disk diffusion agar colony formation assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 10. | ALA1014995 | F | Antitumor activity against human CX-1 cells xenografted in Swiss nu/nu athymic mouse at 160 mg/kg on 4th,8th,12th and 16th day relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA1014996 | F | Antitumor activity against human CX-1 cells xenografted in Swiss nu/nu athymic mouse at 80 mg/kg on 4th,8th,12th and 16th day relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA1014997 | F | Antitumor activity against human CX-1 cells xenografted in Swiss nu/nu athymic mouse at 40 mg/kg on 4th,8th,12th and 16th day relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA1014998 | F | Antitumor activity against human CX-1 cells xenografted in Swiss nu/nu athymic mouse at 20 mg/kg on 4th,8th,12th and 16th day relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA1274406 | F | Antitumor activity against human CX-1 cells xenografted in mouse assessed as tumor growth inhibition at 100 mg/kg, ip for every 4 days 4 doses | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA1274407 | F | Antitumor activity against human CX-1 cells xenografted in mouse assessed as tumor growth inhibition at 5 mg/kg, ip for every 4 days 4 doses | Homo sapiens | 4 | organism-based format | Scientific Literature | ||
| 16. | ALA1274408 | F | Antitumor activity against human CX-1 cells xenografted in mouse assessed as tumor growth inhibition at 10 mg/kg, ip for every 4 days 4 doses | Homo sapiens | 4 | organism-based format | Scientific Literature | ||
| 17. | ALA1274409 | F | Antitumor activity against human CX-1 cells xenografted in mouse assessed as mouse survival at 100 mg/kg, ip for every 4 days 4 doses | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA1274410 | F | Antitumor activity against human CX-1 cells xenografted in mouse assessed as mouse survival at 5 mg/kg, ip for every 4 days 4 doses | Homo sapiens | 4 | organism-based format | Scientific Literature | ||
| 19. | ALA1274411 | F | Antitumor activity against human CX-1 cells xenografted in mouse assessed as mouse survival at 10 mg/kg, ip for every 4 days 4 doses | Homo sapiens | 3 | organism-based format | Scientific Literature | ||
| 20. | ALA5262052 | F | Cytotoxicity against human CX-1 cells measured after 8 days | Homo sapiens | 3 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!